INS and Hyperglycemia: Although basal insulin, in combination with oral antidiabetics (OADs), is an effective first insulin therapy for patients with poorly controlled type 2 diabetes (8), its efficacy eventually reaches a limit in some patients because, while fasting blood glucose may be at target, postprandial hyperglycaemia may continue to rise and contribute to overall glycaemic levels (9).